Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × bermekimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Weight Loss 1 Pancreatic Neoplasms 1 Hematologic Neoplasms 1 Disease 1 Cachexia 1 Adenocarcinoma 1

Interventions

Megestrol Acetate 9 Standard of Care 4 Exercise 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Infliximab 2 Ibuprofen 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 Vitamin D 1 Ultrasonography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03207724 2020-12-30

OnFX

Cedars-Sinai Medical Center

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡